Addressing the Challenges of Translating LRRK2 Biology into Disease‐Modifying Therapies: The LRRK2 Investigative Therapeutics Exchange Initiative

Movement Disorders 2026 Open access

Read full text
Authors: Esther M. Sammler, Francesca Tonelli, Michelle Durborow, Jim McNasby, Todd Sherer, Mahmood Ahmed, Stevan W. Djurić, Kalpana M. Merchant, Alastair Reith, Darryle Schoepp, Christine Klein, Shalini Padmanabhan
+1 more Dario R. Alessi
DOI: 10.1002/mds.70397
Cited by: 1
References: 35

Fields of Study & Subjects

Parkinson's Disease Mechanisms and Treatments Melanoma and MAPK Pathways HER2/EGFR in Cancer Research

Publication details

Journal / source
Movement Disorders
Publisher
Wiley
Volume
41
Issue
9
Pages
2280-2288
Publication date
25 June 2026
Language
EN